Results 291 to 300 of about 472,310 (340)

Kynurenine pathway metabolite alterations in Down syndrome and Alzheimer's disease. [PDF]

Alzheimers Dement
Dos Reis RG, Singulani MP, Forlenza OV, Gattaz WF, Talib LL.   +4 more
europepmc   +1 more source

Plasma p-tau212 as a biomarker of sporadic and Down syndrome Alzheimer's disease. [PDF]

Alzheimers Dement
Kac PR, Alcolea D, Montoliu-Gaya L, Fernández S, Rodriguez JL, Maure L, González-Ortiz F, Benejam B, Turton M, Barroeta I, Harrison P, Videla L, Ashton NJ, Lleó A, Zetterberg H, Carmona-Iragui M, Karikari TK, Fortea J, Blennow K.   +18 more
europepmc   +1 more source

Impact of preventive strategies on IHD mortality in Alzheimer's disease. [PDF]

Int J Cardiol Cardiovasc Risk Prev
Toledo JPC.
europepmc   +1 more source

STING deletion protects against amyloid β-induced Alzheimer's disease pathogenesis. [PDF]

Alzheimers Dement
Thanos JM, Campbell OC, Cowan MN, Bruch KR, Moore KA, Ennerfelt HE, Natale NR, Mangalmurti A, Kerur N, Lukens JR.   +9 more
europepmc   +1 more source

Correction to "Machine learning prediction of tau-PET in Alzheimer's disease using plasma, MRI, and clinical data". [PDF]

Alzheimers Dement
europepmc   +1 more source